2024-07-211263.17 MB77页25
2024-11-0812210.17 MB1页25
2024-07-212203.49 MB14页25
2024-07-211181.71 MB24页25
2024-07-2114212.44 MB42页25
2024-07-2187707.31 KB4页25
2024-07-211341.03 MB38页25
2024-07-211698.32 MB211页25
2024-07-211442.1 MB15页25
2024-07-21588.73 MB33页25
+ModelARTICLEINPRESSNeurologíaxxx(xxxx)xxx—xxxNEUROLOGÍAwww.elsevier.es/neurologiaCONSENSUSSTATEMENTClinicalpracticeguidelinesforthediagnosisandmanagementofCharcot-Marie-ToothdiseaseR.SiveraMascaróa,b,T.GarcíaSobrinoc,∗,A.HorgaHernándezd,A.L.PelayoNegroe,f,A.AlonsoJiménezg,A.AnteloPoseh,M.D.CalabriaGallegoi,C.Casasnovasj,C.A.CemillánFernándezk,J.EstebanPérezl,M.FenollarCortésm,M.Fra... 2024-07-21160557.51 KB15页25
2024-07-21721.19 MB2页25
2024-07-211501.05 MB6页25
2024-07-211261.48 MB3页25
2024-07-211311.29 MB7页25
2024-07-21181369.39 KB4页25
2024-07-21872.19 MB82页25
2024-07-21760885.42 KB14页25
2024-07-21122977.3 KB18页25
DISEASEMANAGEMENTeNSDrugs1997Feb:7(2),98-1101172-7047/97/=2-OO98/$06H)/0©AdisInternationalLimitedAllrightsreservedTrigeminalNeuralgiaAGuidetoDrugChoiceWilliamP.CheshireDepartmentofNeurology,MayoClinicJacksonville,Jacksonville,Florida,USAContentsSummary..,..,981-ClinicalFeatures,,992.DifferentialDiagnosis.993.RationaleforDrugTherapy1003.1Carbamazepine1013.2Phenytoin,...1023.3Baclofen.1023.4Sodi... 2024-07-21972.04 MB13页25